Observational Study
Copyright ©The Author(s) 2017.
World J Hepatol. Mar 28, 2017; 9(9): 477-486
Published online Mar 28, 2017. doi: 10.4254/wjh.v9.i9.477
Table 1 Characteristics of patients with hematological malignant disease included in the study n (%)
CharacteristicTotal (n = 165)
Age (mean ± SD)36.1 ± 23.1
Gender (M)89 (55.6)
ALT (mean ± SD)29.7 ± 32.8
AST (mean ± SD)38.2 ± 49.2
Anti-HCV(+)39 (23.6)
HBsAg(+)13 (7.9)
Anti-HBc(+)/HBsAg(-)54 (32.7)
Clinical characteristics
Malignant lymphoma88 (53.3)
Hodgkin’s disease8 (4.8)
Acute leukemia43 (26.1)
Chronic leukemia23 (13.9)
Multiple myeloma3 (1.8)
Steroid containing treatment110 (66.7)
Table 2 Clinical characteristics of patients with occult hepatitis B and detectable full hepatitis B virus genome
Sample IDAgeGenderDiagnosisAnti-HBs (mIU/L)HBV DNA Log (copies/mL)Mutation1
EGL638MMalignant lymphoma(+)/153.5-
U3155FMalignant lymphoma(-)3.8S143L
EGL480FMalignant lymphoma(+)/18.92.4P120S, S143L
A795MALLNT4.4P120T
D170MMalignant lymphoma(-)3.9P120T
D145MHD(-)3.6P120T